首页> 外文期刊>Journal of neuro-ophthalmology: Official journal of the North American Neuro-Ophthalmology Society >The Visual Impact of Fractionated Stereotactic Conformal Radiotherapy on Seven Eyes With Optic Nerve Sheath Meningiomas.
【24h】

The Visual Impact of Fractionated Stereotactic Conformal Radiotherapy on Seven Eyes With Optic Nerve Sheath Meningiomas.

机译:立体定向保形放射疗法对视神经鞘膜脑膜瘤的七只眼的视觉影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND:: Treatment of primary optic nerve sheath meningiomas (ONSMs) remains controversial. Although recent studies have suggested a favorable outcome of radiotherapy, controlled data on the efficacy of fractionated stereotactic conformal radiotherapy (SCRT) in primary ONSMs are still lacking. METHODS:: Seven eyes treated with SCRT (total dose: 54 Gy) were compared with six eyes that were not treated because of patient or physician preference. The indication for intervention was deterioration of visual function with or without imaging evidence of tumor progression. Patients with secondary ONSMs and those with neurofibromatosis type 2 were excluded. The mean follow-up period was 57 months for the treated eyes and 61 months for the untreated eyes. RESULTS:: Among the seven treated eyes, visual acuity improved in six, five of which sustained improvement of three or more Snellen lines. One eye deteriorated by two lines. Visual field improved in four eyes, remained stable in two, and deteriorated in one. Four untreated eyes showed worsening of visual acuity and two remained stable. Visual field deteriorated in three eyes and was stable in three. None of the untreated eyes experienced improvement in visual acuity or visual field. No complications of treatment were documented. CONCLUSIONS:: In agreement with previous reports, these results indicate that SCRT is superior to observation in its impact on visual function in eyes with primary ONSMs.
机译:背景:原发性视神经鞘膜脑膜瘤(ONSMs)的治疗仍存在争议。尽管最近的研究表明放疗具有良好的疗效,但仍缺乏有关分级立体定向保形放疗(SCRT)在主要ONSM中疗效的对照数据。方法:将七只接受SCRT治疗的眼睛(总剂量:54 Gy)与六只因患者或医生的偏爱而未接受治疗的眼睛进行比较。干预的指征是视觉功能的恶化,无论有无肿瘤进展的影像学证据。排除了继发性ONSM和2型神经纤维瘤病的患者。经治疗的眼睛平均随访期为57个月,未经治疗的眼睛平均随访期为61个月。结果:在接受治疗的七只眼中,有六只的视力得到改善,其中五只持续改善了三个或更多的斯内伦线。一只眼睛恶化了两行。视野改善了四只眼,稳定了两只,一只恶化了。四只未经治疗的眼睛显示视力恶化,两只保持稳定。三只眼视野恶化,三只眼稳定。未经处理的眼睛均未在视敏度或视野方面得到改善。没有记录到治疗并发症。结论:与先前的报告一致,这些结果表明SCRT在其对原发性ONSM的眼睛视觉功能的影响方面优于观察。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号